Comparing the Efficacy of Conservative Treatment With Minimally Invasive Surgery in the Treatment of Rib Fractures

Summary

Open, randomized, parallel controlled prospective clinical study design was used in this study.Subjects were patients with 2-4 displaced non-flail rib fractures.Operation group (Group 1) : minimally invasive internal fixation operation group under spontaneous breathing anesthesia.In the operation group of minimally invasive internal fixation under autonomic respiratory anesthesia, the fracture was determined preoperatively by chest CT+ three-dimensional reconstruction of the ribs, and the optimal incision location was determined. The fracture was exposed through as many small incisions as possible, and fixed with titanium plate or clon-type plate. During the operation, the autonomic respiratory anesthesia and paraviral nerve block technology was adopted.In the conservative group (group 2), routine treatment measures such as analgesia and chest strap fixed were adopted.The purpose of this study was to evaluate the safety, feasibility, and efficacy of minimally invasive and conservative treatment for rib fractures with different Numbers of displaced ends.

Conditions

• Chest Trauma
• Rib Fractures
• Surgery--Complications

Interventions

PROCEDURE

surgical treatment

surgical treatment and Conservative treatment

PROCEDURE

Conservative treatment

Conservative treatment

Sponsors & Collaborators

• Shanghai 6th People's Hospital

  lead OTHER

Principal Investigators

• Yi Yang, PHD · Shanghai 6th People's Hospital

• Zongli Gao, PHD · Shanghai 6th People's Hospital

• Yonghong Zhao, PHD · Shanghai 6th People's Hospital

• Weiming Wu, PHD · Shanghai 6th People's Hospital

• Weigang Zhao, PHD · Shanghai 6th People's Hospital

• Tiancheng Zhao, PHD · Shanghai 6th People's Hospital

• Xiang Guo, PHD · Shanghai 6th People's Hospital

• Lei Wang, PHD · Shanghai 6th People's Hospital

• Weiwei He, PHD · Shanghai 6th People's Hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-03-01

Primary Completion

2023-06-10

Completion

2024-06-30